Suchergebnisse - "Mertens, Daniel"

PubPharm (10)

1

Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors

enthalten in: International journal of cancer | 2022

von Wolf, C. | Maus, C. | Persicke, M. | +8

2

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia

enthalten in: Haematologica | 2019

von Tausch, E. | Close, W. | Dolnik, A. | +6

CommentIn: Haematologica. 2019 Nov;104(11):e540. - PMID 31666345

3

IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia

enthalten in: Blood | 2019

von Scheffold, A. | Jebaraj, B. | Tausch, E. | +17

CommentIn: Blood. 2019 Aug 8;134(6):496-498. - PMID 31395581

4

Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia

enthalten in: International journal of cancer | 2015

von Opel, D. | Schnaiter, A. | Dodier, D. | +7

5

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab : results from the CLL2H trial of the GCLLSG

enthalten in: Blood | 2013

von Schnaiter, A. | Paschka, P. | Rossi, M. | +13

6

Treating chronic lymphocytic leukemia with thalidomide and lenalidomide

enthalten in: Expert opinion on pharmacotherapy | 2011

von Giannopoulos, K. | Mertens, D. | Stilgenbauer, S.

7

Immune modulatory agents in hematopoietic malignancies

enthalten in: Cancer treatment reviews | 2011

von Idler, I. | Bhattacharya, N. | Döhner, H. | +2

8

High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay

enthalten in: International journal of cancer | 2010

von Bhattacharya, N. | Sarno, A. | Idler, I. | +5

9

Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells

enthalten in: British journal of haematology | 2010

von Idler, I. | Giannopoulos, K. | Zenz, T. | +5

10

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL) : dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

enthalten in: Blood | 2009

von Zenz, T. | Häbe, S. | Denzel, T. | +10

1
[1]